175 related articles for article (PubMed ID: 31733305)
1. The novel axis of YAP1, transcription enhancer factor 3 and Down Syndrome Candidate Region 1 isoform 1L is a common signaling pathway downstream of several angiogenic factors.
Cui P; Liu X; Zhao K; Hou S; Chen C; Zhao D; Zeng H
Microvasc Res; 2020 May; 129():103955. PubMed ID: 31733305
[TBL] [Abstract][Full Text] [Related]
2. A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis.
Hou S; Niu G; Liu X; Bourbon PM; Zhang D; Cui P; Zhao K; Zhao D; Zeng H
Microvasc Res; 2021 Nov; 138():104209. PubMed ID: 34146582
[TBL] [Abstract][Full Text] [Related]
3. Transcription enhancer factor 3 (TEF3) mediates the expression of Down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells.
Liu X; Zhao D; Qin L; Li J; Zeng H
J Biol Chem; 2008 Dec; 283(49):34159-67. PubMed ID: 18840614
[TBL] [Abstract][Full Text] [Related]
4. Requirement of the nuclear localization of transcription enhancer factor 3 for proliferation, migration, tube formation, and angiogenesis induced by vascular endothelial growth factor.
Liu X; Zhao D; James L; Li J; Zeng H
FASEB J; 2011 Apr; 25(4):1188-97. PubMed ID: 21169383
[TBL] [Abstract][Full Text] [Related]
5. Down Syndrome Candidate Region 1 Isoform 1L regulated tumor growth by targeting both angiogenesis and tumor cells.
Chen C; Cui P; Zhao K; Niu G; Hou S; Zhao D; Zeng H
Microvasc Res; 2022 Mar; 140():104305. PubMed ID: 34958805
[TBL] [Abstract][Full Text] [Related]
6. Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway.
Qin L; Zhao D; Liu X; Nagy JA; Hoang MV; Brown LF; Dvorak HF; Zeng H
Mol Cancer Res; 2006 Nov; 4(11):811-20. PubMed ID: 17114339
[TBL] [Abstract][Full Text] [Related]
7. Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics the inhibitory effects of DSCR1 on calcineurin signaling in endothelial cells and inhibits angiogenesis.
Gollogly LK; Ryeom SW; Yoon SS
J Surg Res; 2007 Sep; 142(1):129-36. PubMed ID: 17610901
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of angiogenic cellular processes and claudin-5 by histamine and VEGF via PI3K-signaling, transcription factor SNAI2 and interleukin-8.
Laakkonen JP; Lappalainen JP; Theelen TL; Toivanen PI; Nieminen T; Jauhiainen S; Kaikkonen MU; Sluimer JC; Ylä-Herttuala S
Angiogenesis; 2017 Feb; 20(1):109-124. PubMed ID: 27873103
[TBL] [Abstract][Full Text] [Related]
9. Secretion of Down Syndrome Critical Region 1 Isoform 4 in Ischemic Retinal Ganglion Cells Displays Anti-Angiogenic Properties Via NFATc1-Dependent Pathway.
Xu Y; Yang B; Hu Y; Lu L; Lu X; Wang J; Shu Q; Cheng Q; Yu S; Xu F; Huang J; Liang X
Mol Neurobiol; 2017 Oct; 54(8):6556-6571. PubMed ID: 27734335
[TBL] [Abstract][Full Text] [Related]
10. Down syndrome candidate region 1,a downstream target of VEGF, participates in endothelial cell migration and angiogenesis.
Iizuka M; Abe M; Shiiba K; Sasaki I; Sato Y
J Vasc Res; 2004; 41(4):334-44. PubMed ID: 15263820
[TBL] [Abstract][Full Text] [Related]
11. YAP1-TEAD1 signaling controls angiogenesis and mitochondrial biogenesis through PGC1α.
Mammoto A; Muyleart M; Kadlec A; Gutterman D; Mammoto T
Microvasc Res; 2018 Sep; 119():73-83. PubMed ID: 29680477
[TBL] [Abstract][Full Text] [Related]
12. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?
Yao YG; Duh EJ
Biochem Biophys Res Commun; 2004 Aug; 321(3):648-56. PubMed ID: 15358155
[TBL] [Abstract][Full Text] [Related]
13. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
14. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells.
Hesser BA; Liang XH; Camenisch G; Yang S; Lewin DA; Scheller R; Ferrara N; Gerber HP
Blood; 2004 Jul; 104(1):149-58. PubMed ID: 15016650
[TBL] [Abstract][Full Text] [Related]
15. Plasma membrane calcium ATPase isoform 4 inhibits vascular endothelial growth factor-mediated angiogenesis through interaction with calcineurin.
Baggott RR; Alfranca A; López-Maderuelo D; Mohamed TM; Escolano A; Oller J; Ornes BC; Kurusamy S; Rowther FB; Brown JE; Oceandy D; Cartwright EJ; Wang W; Gómez-del Arco P; Martínez-Martínez S; Neyses L; Redondo JM; Armesilla AL
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2310-20. PubMed ID: 25147342
[TBL] [Abstract][Full Text] [Related]
16. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1.
Liu J; Razani B; Tang S; Terman BI; Ware JA; Lisanti MP
J Biol Chem; 1999 May; 274(22):15781-5. PubMed ID: 10336480
[TBL] [Abstract][Full Text] [Related]
18. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
[TBL] [Abstract][Full Text] [Related]
19. Defining an Upstream VEGF (Vascular Endothelial Growth Factor) Priming Signature for Downstream Factor-Induced Endothelial Cell-Pericyte Tube Network Coassembly.
Bowers SLK; Kemp SS; Aguera KN; Koller GM; Forgy JC; Davis GE
Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):2891-2909. PubMed ID: 33086871
[TBL] [Abstract][Full Text] [Related]
20. miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling.
Yan XC; Cao J; Liang L; Wang L; Gao F; Yang ZY; Duan JL; Chang TF; Deng SM; Liu Y; Dou GR; Zhang J; Zheng QJ; Zhang P; Han H
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
